Literature DB >> 22775208

Novel actions of progesterone: what we know today and what will be the scenario in the future?

Shilpa N Kaore1, Deepak Kumar Langade, Vijay Kumar Yadav, Parag Sharma, Vijay R Thawani, Raj Sharma.   

Abstract

OBJECTIVES: This article is aimed to review the novel actions of progesterone, which otherwise is considered as a female reproductive hormone. The article focuses on its important physiological actions in males too and gives an overview of its novel perspectives in disorders of central and peripheral nervous system. KEY
FINDINGS: Progesterone may have a potential benefit in treatment of traumatic brain injury, various neurological disorders and male related diseases like benign prostatic hypertrophy (BPH), prostate cancer and osteoporosis. Norethisterone (NETA), a progesterone derivative, decreases bone mineral loss in male castrated mice suggesting its role in osteoporosis. In the future, progesterone may find use as a male contraceptive too, but still needs confirmatory trials for safety, tolerability and acceptability. Megestrol acetate, a progesterone derivative is preferred in prostatic cancer. Further, it may find utility in nicotine addiction, traumatic brain injury (recently entered Phase III trial) and Alzheimer's disease, diabetic neuropathy and crush injuries. Studies also suggest role of progesterone in stroke, for which further clinical trials are needed. The non genomic actions of progesterone may be in part responsible for these novel actions.
SUMMARY: Although progesterone has shown promising role in various non-hormonal benefits, further clinical studies are needed to prove its usefulness in conditions like stroke, traumatic brain injury, neuropathy and crush injury. In male related illnesses like BPH and prostatic Ca, it may prove a boon in near future. New era of hormonal male contraception may be initiated by use of progesterone along with testosterone.
© 2012 The Authors. JPP © 2012 Royal Pharmaceutical Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22775208     DOI: 10.1111/j.2042-7158.2012.01464.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  10 in total

Review 1.  Progesterone-based compounds affect immune responses and susceptibility to infections at diverse mucosal sites.

Authors:  Olivia J Hall; Sabra L Klein
Journal:  Mucosal Immunol       Date:  2017-04-12       Impact factor: 7.313

2.  Progesterone protects endothelial cells after cerebrovascular occlusion by decreasing MCP-1- and CXCL1-mediated macrophage infiltration.

Authors:  Ebony Washington Remus; Iqbal Sayeed; Soonmi Won; Alicia N Lyle; Donald G Stein
Journal:  Exp Neurol       Date:  2015-07-17       Impact factor: 5.330

Review 3.  Undernutrition and HIV Infection in Sub-Saharan Africa: Health Outcomes and Therapeutic Interventions.

Authors:  Hubaida Fuseini; Ben A Gyan; George B Kyei; Douglas C Heimburger; John R Koethe
Journal:  Curr HIV/AIDS Rep       Date:  2021-02-19       Impact factor: 5.071

4.  Combined liquid chromatography-tandem mass spectrometry analysis of progesterone metabolites.

Authors:  Maša Sinreih; Sven Zukunft; Izidor Sosič; Jožko Cesar; Stanislav Gobec; Jerzy Adamski; Tea Lanišnik Rižner
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

5.  Progesterone-Based Therapy Protects Against Influenza by Promoting Lung Repair and Recovery in Females.

Authors:  Olivia J Hall; Nathachit Limjunyawong; Meghan S Vermillion; Dionne P Robinson; Nicholas Wohlgemuth; Andrew Pekosz; Wayne Mitzner; Sabra L Klein
Journal:  PLoS Pathog       Date:  2016-09-15       Impact factor: 6.823

6.  Continuous and intermittent theta burst stimulation to the visual cortex do not alter GABA and glutamate concentrations measured by magnetic resonance spectroscopy.

Authors:  Karlene S Stoby; Sara A Rafique; Georg Oeltzschner; Jennifer K E Steeves
Journal:  Brain Behav       Date:  2022-01-14       Impact factor: 2.708

7.  Inhibiting 3βHSD1 to eliminate the oncogenic effects of progesterone in prostate cancer.

Authors:  Zemin Hou; Shengsong Huang; Zejie Mei; Longlong Chen; Jiacheng Guo; Yuanyuan Gao; Qian Zhuang; Xuebin Zhang; Qilong Tan; Tao Yang; Ying Liu; Yongnan Chi; Lifengrong Qi; Ting Jiang; Xuefeng Shao; Yan Wu; Xiaojun Xu; Jun Qin; Ruobing Ren; Huiru Tang; Denglong Wu; Zhenfei Li
Journal:  Cell Rep Med       Date:  2022-03-15

8.  Towards engineering hormone-binding globulins as drug delivery agents.

Authors:  Wee Lee Chan; Aiwu Zhou; Randy J Read
Journal:  PLoS One       Date:  2014-11-26       Impact factor: 3.240

9.  Progesterone Treatment Shows Benefit in Female Rats in a Pediatric Model of Controlled Cortical Impact Injury.

Authors:  Rastafa I Geddes; Bethany L Peterson; Donald G Stein; Iqbal Sayeed
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

10.  Assessing differential effects of single and accelerated low-frequency rTMS to the visual cortex on GABA and glutamate concentrations.

Authors:  Sara A Rafique; Jennifer K E Steeves
Journal:  Brain Behav       Date:  2020-09-23       Impact factor: 2.708

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.